Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC

The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent.

Shelter Pharma Limited has secured a significant international order from FIRSTVET Veterinary Medicines Trading LLC, a Dubai-based entity. This order, valued at USD 6,700, is for the supply of Feed Supplements and Herbal Medicine products. The order is a fixed-cost contract, and the company is expected to fulfil it within a two-month timeframe. This international order underscores Shelter Pharma's growing global presence and its ability to cater to the needs of international clients.

Shelter Pharma Limited has secured another noteworthy international order, this time from Genet International, a Bangladesh-based company. The order, worth USD 12,500, is for the preparation of a specific kind of animal feed. Similar to the previous order, this is a fixed-cost contract with a two-month execution timeline. This order further solidifies Shelter Pharma's position as a reliable supplier of animal healthcare products and solutions in the international market.

Shelter Pharma Limited is a prominent pharmaceutical and nutraceutical company renowned for its dedication to research, innovation and quality. Established to provide accessible and effective healthcare solutions, the company has consistently delivered products that meet the highest industry standards. Their state-of-the-art facilities, world-class team of experts and commitment to ethical practices have earned them a reputation of trust in the industry. Shelter Pharma's mission is to promote well-being and health through innovative, high-quality nutraceuticals.

On Wednesday, shares of Shelter Pharma Ltd surged over 8 per cent to Rs 51 per share from its previous closing of Rs 47.15 per share. The stock’s 52-week high is Rs 80.90 and its 52-week low is Rs 38.01. The stock falls under S&P BSE SME IPO with a lot size of 3,000 shares.

The company has a market cap of Rs 57.17 crore. The company’s current debt is Rs 0.57 crore which is less than 1 per cent of the market cap. The promoters own more than half of the company's shares, with 54.97 per cent while the general public owns the rest, with 45.03 per cent as of September 2024. There are 1,119 public shareholders as of September 2024.

The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. The stock is up 34.21 per cent from its 52-week low of Rs 38.01 per share.

Disclaimer: The article is for informational purposes only and not investment advice.